SRB Corp’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-724
| Closed | -$697K | – | 71 |
|
|
2024
Q1 | $697K | Buy |
724
+86
| +13% | +$82.8K | 0.04% | 64 |
|
|
2023
Q4 | $560K | Buy |
638
+82
| +15% | +$72K | 0.03% | 30 |
|
|
2023
Q3 | $458K | Sell |
556
-30
| -5% | -$24.7K | 0.03% | 60 |
|
|
2023
Q2 | $421K | Buy |
586
+100
| +21% | +$71.9K | 0.02% | 90 |
|
|
2023
Q1 | $399K | Sell |
486
-127
| -21% | -$104K | 0.03% | 15 |
|
|
2022
Q4 | $442K | Sell |
613
-67
| -10% | -$48.3K | 0.03% | 68 |
|
|
2022
Q3 | $468K | Sell |
680
-1,564
| -70% | -$1.08M | 0.03% | 14 |
|
|
2022
Q2 | $1.33M | Buy |
2,244
+82
| +4% | +$48.5K | 0.09% | 64 |
|
|
2022
Q1 | $1.51M | Hold |
2,162
| – | – | 0.08% | 40 |
|
|
2021
Q4 | $1.37M | Sell |
2,162
-384
| -15% | -$242K | 0.07% | 86 |
|
|
2021
Q3 | $1.54M | Buy |
+2,546
| New | +$1.54M | 0.09% | 79 |
|
|
2021
Q2 | – | Sell |
-3,280
| Closed | -$1.55M | – | 103 |
|
|
2021
Q1 | $1.55M | Buy |
3,280
+1,786
| +120% | +$845K | 0.11% | 57 |
|
|
2020
Q4 | $721K | Buy |
1,494
+558
| +60% | +$269K | 0.05% | 155 |
|
|
2020
Q3 | $524K | Buy |
+936
| New | +$524K | 0.04% | 130 |
|
|
2020
Q2 | – | Sell |
-1,343
| Closed | -$656K | – | 165 |
|
|
2020
Q1 | $656K | Sell |
1,343
-150
| -10% | -$73.3K | 0.06% | 12 |
|
|
2019
Q4 | $561K | Hold |
1,493
| – | – | 0.05% | 35 |
|
|
2019
Q3 | $414K | Buy |
+1,493
| New | +$414K | 0.04% | 155 |
|
|
2019
Q2 | – | Sell |
-1,683
| Closed | -$691K | – | 181 |
|
|
2019
Q1 | $691K | Hold |
1,683
| – | – | 0.07% | 97 |
|
|
2018
Q4 | $629K | Buy |
+1,683
| New | +$629K | 0.07% | 11 |
|